ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3227

Identification of Novel Protein-Coding Genetic Variants Associated with Takayasu Arteritis

Paul Renauer1, Patrick Coit1, Peter A. Merkel2 and Amr H. Sawalha1, 1Division of Rheumatology, University of Michigan, Ann Arbor, MI, 2Penn Vasculitis Center, Division of Rheumatology, University of Pennsylvania, Philadelphia, PA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: genetics, GWAS, takayasu arteritis and vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Vasculitis IV

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Takayasu arteritis is a rare large vessel vasculitis of unclear etiology. Previous studies identified associations between Takayasu arteritis and genetic variants within HLA class I and II, FCGR2A/FCGR3A, IL12B, RPS9/LILRB3, IL6, and chromosome 21q22. The purpose of this study was to uncover protein-coding genetic risk variants in Takayasu arteritis.

Methods: We analyzed 230,050 exonic protein-coding genetic variants included on the Illumina Human Exome BeadChip array in a European-American cohort consisting of 134 patients with Takayasu arteritis and 1051 healthy controls. Genotyping data were subjected to rigorous quality control assessment and filtering prior to genetic analysis.

Results: Outside of the HLA region, 4 nonsynonymous protein-coding variants associated with increased risk for Takayasu arteritis were identified (P<5X10-5). The most significant genetic associations were with missense genetic variants in TXK (OR= 1.95, P= 7.75X10-6) and CCDC91 (OR= 3.69, P= 2.11X10-5). TXK encodes a non-receptor tyrosine kinase that plays an important role in T cell function and differentiation. CCDC91 encodes P56 which interacts with the trans-Golgi network and is involved in regulating protein trafficking. Evidence for gene-gene epistatic interaction was detected between the two genetic variants in TXK and CCDC91 and the risk for Takayasu arteritis (interaction OR= 3.09, P= 2.38X10-2). Two additional missense variants within the collagen gene COL11A2 and the acyl-coenzyme A synthetase gene ACSM5 were also associated with Takayasu arteritis (P= 3.27X10-5 and 3.41X10-5, respectively).

Conclusion: Missense protein-coding variants associated with increased risk for Takayasu arteritis were identified. A larger cohort will be necessary to confirm these associations with a genome-wide level of significance.


Disclosure: P. Renauer, None; P. Coit, None; P. A. Merkel, None; A. H. Sawalha, None.

To cite this abstract in AMA style:

Renauer P, Coit P, Merkel PA, Sawalha AH. Identification of Novel Protein-Coding Genetic Variants Associated with Takayasu Arteritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/identification-of-novel-protein-coding-genetic-variants-associated-with-takayasu-arteritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/identification-of-novel-protein-coding-genetic-variants-associated-with-takayasu-arteritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology